February 20, 2008 – Mobile Anesthesiologists Holdings LLC (Mobile) has announced the spin-off of its procurement operation into an independently operating company to be known as Pro Cure LLC, a company that will provide a full spectrum of procurement services to the rapidly growing ‘alternate-site’ market comprised of office-based practices as well as smaller chain and independent ASCs.
The alternate site market is the fastest growing segment in healthcare as an increasing number of surgical and diagnostic procedures are being migrated from hospitals, said the company. According to the SMG Group, in 2007 25 percent of all surgical/diagnostic procedures were performed in the office-based setting and it is projected that over 50 percent of all procedures will be migrated by 2010. Fueling this exponential growth is the fact that the delivery of medical care at alternate sites, specifically ambulatory surgery centers and physicians offices is as safe or safer than the hospital setting but significantly less expensive, according to the company.
Pro Cure has reportedly built its business model around this cost disparity. Pro Cure aims to provider independent healthcare provider organizations the same benefit from the pricing advantages enjoyed by hospitals and corporate chains.
In late 2007, Mobile began offering its internal procurement resources to outside clients saving them as much as 60 percent on anesthesia specific drugs and up to 30 percent on average on their overall procurement portfolio, said the company.
On Feb. 19, Pro Cure, officially started to operate independently of Mobile Anesthesiologists with Scott C. Mayer as president and Richard J. Harris as executive chairman.
For more information: www.pro-curemed.com
May 14, 2024 
